Oncolytic Virus Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
17
NCT05904236
Safety and Tolerability of Intravenous Administration of ICVB-1042
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 1, 2023
Completion: Dec 20, 2024
Loading map...